Deferred treatment for clinically localized prostate cancer.

Deferred treatment for clinically localized prostate cancer.
复制标题

DOI:
10.1016/s0748-7983(95)92087-0
复制
发表时间:
1995-08-01
期刊:
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
影响因子:
--
通讯作者:
Adolfsson, J
Adolfsson, J
中科院分区:
其他
文献类型:
--
作者:
Adolfsson, J

文献摘要

被引文献

相似文献

根据现有数据,对于预期寿命在10年或以下的低级别临床局限性前列腺癌患者,延迟治疗绝对是一种选择,并且可以避免治疗的副作用。许多患者将在他们的余生中避免治疗前列腺癌的需要。
With the available data, deferred treatment is definitely an option for patients with low grade clinically localized prostate cancer if their life expectancy is 10 years or less and avoids the side-effects of treatment. Many patients will avoid the need for therapy of their prostate cancer during their remaining lifetime.